Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma
Guanghao Zhu, Wei Wang, Hui Yao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients
Lin Shen, Yanyan Li, Na Li, et al.
Aging (2022) Vol. 14, Iss. 9, pp. 4050-4068
Open Access | Times Cited: 7
Alterations of histone modifications in cancer
Maha Saber-Ayad, Wafaa S. Ramadan, Raafat El‐Awady
Elsevier eBooks (2023), pp. 85-172
Closed Access | Times Cited: 3
Deacetylation of Histones and Non-histone Proteins in Inflammatory Diseases and Cancer Therapeutic Potential of Histone Deacetylase Inhibitors
Ezgi Man, Serap Evran
Current Genomics (2023) Vol. 24, Iss. 3, pp. 136-145
Open Access | Times Cited: 3
Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer
Ellen Finnegan, Wei Ding, Žiga Ude, et al.
Cellular Oncology (2023) Vol. 47, Iss. 2, pp. 533-553
Open Access | Times Cited: 3
Directed evolution of biomass intensive CHO cells by adaptation to sub-physiological temperature
Katie Louise Syddall, Alejandro Fernandez‐Martell, Joseph A. Cartwright, et al.
Metabolic Engineering (2023) Vol. 81, pp. 53-69
Open Access | Times Cited: 3
Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer
Qihe Jiang, Yu-Jiang Tang, Qing-lan Hu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116315-116315
Closed Access
Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview
Elsie Neo Seane, Shankari Nair, Charlot Vandevoorde, et al.
(2024)
Open Access
Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview
Elsie Neo Seane, Shankari Nair, Charlot Vandevoorde, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 602-602
Open Access
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis
Sashikanta Swain, Ravi Kant Narayan, P Mishra
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Design and optimization of novel Tetrahydro-β-carboline-based HDAC inhibitors with potent activities against tumor cell growth and metastasis
Shule Fan, Zeyi Wan, Yuhua Qu, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 114, pp. 129986-129986
Closed Access
M6A and lactylation modification-related signature predicts prognosis and immunotherapy response in hepatocellular carcinoma
Ren Hui-li, Jianhua Liu, Shaohui Zhang
(2024)
Closed Access
Discovery of cloxiquine derivatives as potent HDAC inhibitors for the treatment of melanoma via activating PPARγ
Limin Yang, Ran Ding, Tong Xiao-jie, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117029-117029
Closed Access
Recent Advances in Phytochemical Research for Cancer Treatment
Dexter Achu Mosoh
IntechOpen eBooks (2024)
Open Access
NSC-3852 synergistically enhances the cytotoxicity of olaparib in oral squamous cell carcinoma
Yuka Sasaki, Takuma Inouchi, Chie Kise, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 744, pp. 151166-151166
Closed Access
Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
Xiaoqian Hu, Xiao-Chong Zhang, Shao-Teng Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 1
Mechanism of assembly, activation and lysine selection by the SIN3B histone deacetylase complex
Mandy S. M. Wan, Reyhan Muhammad, Marios G. Koliopoulos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
CRISPR, epigenetics, and cancer
Andrea Martella
Elsevier eBooks (2023), pp. 687-707
Closed Access
AN OVERVIEW OF THE RELATIONSHIP BETWEEN DIETARY BEHAVIOR AND LIFESTYLE TO HEALTH AT MOLECULAR BIOLOGY MECHANISM
Ngoc Le, Hoang Nam NGUYEN, Thi Minh Nguyet NGUYEN
Tạp chí Dinh dưỡng và Thực phẩm (2023) Vol. 19, Iss. 3, pp. 1-15
Open Access
Comprehensive analysis of Histone deacetylases genes in the prognosis and immune infiltration of glioma patients
Aibin Liu, Yanyan Li, Lin Shen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in pancreatic cancer
Carter A. Wright, Emily R. Gordon, Sara J. Cooper
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Previous Page - Page 2

Scroll to top